CONSUN PHARMA (01681): Lee Cheuk Kwong appointed as Independent Non-executive Director.
Kangzin Pharmaceutical (01681) announced that, effective from February 24, 2025, Ms. Chen Yujun has resigned as an independent...
CONSUN PHARMA (01681) announced that, effective from February 24, 2025: Ms. Chen Yujun has resigned as an independent non-executive director and will no longer serve as chairperson of the audit committee, and as a member of the nomination committee, remuneration committee, and ESG committee; Mr. Li Zhuoguang has been appointed as an independent non-executive director, chairperson of the audit committee, and as a member of the nomination committee, remuneration committee, and ESG committee; Mr. Fang Peicheng will no longer concurrently serve as the Chief Financial Officer; Ms. Chen Yujun has been appointed as the Chief Financial Officer.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


